Ribosomal RNA-based epitranscriptomic regulation of chondrocyte translation and proteome in osteoarthritis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Osteoarthritis-related cartilage extracellular matrix remodeling is dependent on changes in chondrocyte protein expression. Yet, the role of ribosomes in chondrocyte translation regulation is unknown. In this exploratory study, we investigated ribosomal RNA (rRNA) epitranscriptomic-based ribosome heterogeneity in human articular chondrocytes and its relevance for osteoarthritis.

Related collections

Most cited references 54

Record: found
Abstract: found
Article: not found

The Protein Data Bank.

H M Berman, J Westbrook, Z. Feng … (2000)

The Protein Data Bank (PDB; http://www.rcsb.org/pdb/ ) is the single worldwide archive of structural data of biological macromolecules. This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.

0 comments Cited 3677 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: not found
Article: not found

Improved vectors and genome-wide libraries for CRISPR screening.

Neville Sanjana, Ophir Shalem, Feng Zhang (2014)

0 comments Cited 1375 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Genome-scale CRISPR-Cas9 knockout screening in human cells.

Ophir Shalem, Neville Sanjana, Ella Hartenian … (2014)

The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a new way to interrogate gene function on a genome-wide scale. We show that lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO) library targeting 18,080 genes with 64,751 unique guide sequences enables both negative and positive selection screening in human cells. First, we used the GeCKO library to identify genes essential for cell viability in cancer and pluripotent stem cells. Next, in a melanoma model, we screened for genes whose loss is involved in resistance to vemurafenib, a therapeutic RAF inhibitor. Our highest-ranking candidates include previously validated genes NF1 and MED12, as well as novel hits NF2, CUL3, TADA2B, and TADA1. We observe a high level of consistency between independent guide RNAs targeting the same gene and a high rate of hit confirmation, demonstrating the promise of genome-scale screening with Cas9.